Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence
Lorenza Torti,
Nicolina Ardu,
Laura Maffei,
Paolo De Fabritiis,
Francesco Sorrentino
Affiliations
Lorenza Torti
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome Italy
Nicolina Ardu
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome Italy
Laura Maffei
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome Italy
Paolo De Fabritiis
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome Italy
Francesco Sorrentino
Hemoglobinopathies Unit, Hematology Department, S. Eugenio Hospital (ASL Roma 2) Regional Center for the Diagnosis and Treatment of Rare Anemias and Disorders of Iron Metabolism Rome Italy